LitAlert ~~ GeneLit.com

    • Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy.
    • Sekine M, Enomoto T, Arai M, Den H, Nomura H, Ikeuchi T, Nakamura S, and the Registration Committee of the Japanese Organization of Hereditary Breast and Ovarian Cancer.
    • J Gynecol Oncol. 2022 Jul;33(4):e46. doi: 10.3802/jgo.2022.33.e46. Epub 2022 Mar 31.
    • 3

    • Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
    • Abreu do Valle H, Kaur P, Kwon JS, Cheifet R, Dawson L, Hanley GE.
    • J Gynecol Oncol. 2022 Jul;33(4):e51. doi: 10.3802/jgo.2022.33.e51. Epub 2022 Mar 30.
    • Hereditary breast cancer and fertility preservation outcomes.
    • Arab S, Tulandi T, Buckett W.
    • Assist Reprod Genet. 2022 Apr 11. doi: 10.1007/s10815-022-02486-0. Epub ahead of print.